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Project
"Chemical analysis, risk assessment and elimination of
selected cytostatic agents from hospital waste water", per-
formed at the University Hospital (AKH) Vienna.
Methods
Drugs: 5-fluorouracil, doxorubicin, epirubicin, daunoru-
bicin, cisplatin, carboplatin, oxaliplatin. Model calcula-
tion: Minimum, maximum annual average
concentrations and cumulative amount in hospital sew-
age were calculated. Parameters: drug, water consumption
in the oncologic in-patient treatment ward, renal human
excretion rate. Chemical analysis: platinum compounds:
ICP-MS (speciation analysis by on-line coupling of HPLC
to ICP-MS), limits of detection: cisplatin (0.09 μg/l), car-
boplatin (0.1 μg/l), oxaliplatin (0.15 μg/l). Anthracy-
clines: solid phase extraction, HPLC and fluorescence
detection (FLD), limits of detection: doxorubicin (0.05
μg/l), daunorubicin (0.06 μg/l). 5-Fluorouracil: solid
phase extraction, capillary electrophoresis, limit of detec-
tion 1.7 μg/l. Chemical monitoring: waste water samples:
effluent of (a) the total hospital (TH), (b) the oncological
ward (OW), collected before dilution in the Vienna sewer
system for a total period of 98 days.
Results
Pt concentrations ranged from 3.2 to 266 μg/l; estimates
revealed that about one third of the administered drugs
was detected in the waste water of the oncologic ward. 5-
Fluorouracil was detected in waste water up to 124 μg/l,
doxorubicin up to 1.35 μg/l. The concentrations deter-
mined chemically agreed with the predictions based upon
model calculations.
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